Accutane Class Action

Accutane Class Action

⊆ August 24th, 2010 | ≡ Topic: Accutane Class Action, Accutane Class Action Lawsuit, Accutane Class Action Lawsuits | | ˜

Accutane® Class Action

Accutane Class Action is a blog and directory dedicated to providing information regarding Accutane®. Information presented on http://www.accutaneclassaction.info is not intended as legal advice. If you need legal advice you should contact an attorney immediately.

Accutane® is a powerful oral medication that belongs to the family of the retinoids, also referred to as isotretinoin. A treatment with Accutane® is typically 4 to 5 months long for clearing up acne for a year or so, time enough to develop other potential risks that are not advertised with the drug.

Isotretinoin, a derivative of Vitamin A, is sold by Hoffman-La Roche Pharmaceuticals as either Accutane® or Roaccutane®. Accutane® was discovered to be a leading factor in birth defects as well as causing suicidal depression with the possibility of influencing other psychoses, joint and muscle pains, reduced night vision, thinning of the hair, headaches, increased sensitivity to sunburn, chapped lips, dry itchy skin, development of rashes, dryness of the nose, mild nosebleeds and Irritation of the eyes. Other severe conditions include intestinal and urinary complications.

This blog is intended to bring information to the public about Accutane® and to help individuals get information from a Accutane® Lawyer. Our primary focus will be to address how those effected by Accutane® can seek to recover from the devastation Accutane® inflicted in their lives. Although no amount of financial recovery may suffice to return what has been lost to the people affected by this drug, they none the less deserve to be financially compensated.

If you are a law firm working with victims of Accutane® and would like to add content to this website, please email us at info@masstortamerica.com or you can use the contact form on this page. Accutane® Lawyers are needed to protect the rights of the victims of Accutane®.

Accutane Mass Tort Alert

⊆ August 24th, 2010 | ≡ Topic: Accutane Class Action, Accutane Class Action Lawsuit, Accutane Class Action Lawsuits | | ˜

MASS TORT AMERICA

CLIENT AGGREGATION SERVICES

MASS TORT ALERT

For client aggregation assistance, contact (210) 635-0468 or info@masstortamerica.com.

Ongoing Mass Tort Action:

Accutane® (isotretinoin) severe nodular acne treatment

Potential Defendant(s)

  • Primary: Hoffmann-La Roche, Inc.
  • Primary Defendant Financial Data: Revenues: 2009 $49.1B, 2008 $49.5B
  • Secondary: Prescribing Physicians, Testing Laboratories, and other entities in the distribution chain. Financial Condition Varies, Mostly Insured.

Potential Plaintiffs

  • Individuals prescribed Accutane®.

Potential Plaintiff Numerosity

Potential Plaintiff Claims

  • Wrongful Death, Permanent Disability, Life-Threatening Permanent Injury, Medical Malpractice.

Potential Cause of Action

Accutane® can cause severe, life-threatening birth defects of the baby’s ears, eyes,

face, skull, heart, and brain. Accutane® has also been linked to suicidal ideation and

suicide.

Aggravating Circumstance: Manufacturer has received FDA Warning for “false or

misleading promotional activities” regarding the safety of Accutane®.

“My investigation demonstrates the insidious nature of how the manufacturer, Roche,

and the FDA continue to mislead Advisory Committees and the American people.”

“The off-label use of Accutane® is so prevalent, that some experts estimate that the

improper use was close to 90% among women.”

“I stated that Roche cannot be trusted and will mislead this Advisory Committee as to

birth defects and adverse events related to Accutane®. As my investigation has shown

by June of 2001, it appears that the FDA could no longer trust Roche officials to tell them

the truth or to provide them with documentation.” — 2007 Statement – Congressman

Bart Stupak – FDA Advisory Committee Hearing on iPLEDGE – August 1, 2007

Client Origination and Aggregation Challenges

Many of the potential plaintiffs injured by prescription use of Accutane® may not be

aware that Accutane® has caused their injury or the death of their loved one. The issue

has received press coverage however , adequate publicity has not occurred to ensure

that all those potentially injured by Accutane are aware of the cause. *Contact us to

discuss our client aggregation services (210) 635-0468 info@masstortamerica.com.

Opportunity

Although this issue is past the initial phase of awareness, there are still a vast number

of potential clients in need of legal assistance. Due to the fact that the use of Accutane

was so wide spread, this issue is likely to remain alive for a lengthy period. *Contact us

to discuss our client aggregation services (210) 635-0468 info@masstortamerica.com.

Client Generation Strategy

Internet search engine domination followed by mass press release. This two-pronged

strategy should be sufficient to aggregate a significant number of plaintiffs. Other forms

of advertising including television could be indicated if justified by the plaintiff volume

acquired in the initial plaintiff aggregation phase. *Contact us to discuss our client

aggregation services (210) 635-0468 info@masstortamerica.com.

Disclaimer

If you are not an Attorney this information is not intended for you. If you need legal help,

please seek the advice of an Attorney. If you need medical help, please seek the advice

of a Medical Doctor. No one should discontinue the use of any medication without

seeking the advice of a Medical Doctor.

The information provided in this alert is not intended to be legal advice. This alert is

provided directly to practicing attorneys and is for the sole use of those attorneys.

Further dissemination of this alert is prohibited. It is assumed that the receiving attorney

has the ability to conduct independent research on the information provided and does

not need to rely solely on the provided information for any purpose.

Accutane® is a registered trademark of F. Hoffmann–La Roche Ltd. Mass Tort America

is not affiliated with Accutane® or F. Hoffmann-La Roche Ltd.

References